Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
SBFM Sunshine Biopharma
- 2.7500
- +0.0400+1.48%
Close Dec 13 16:00 ET
- 2.6501
- -0.0999-3.63%
Post 19:42 ET
5.50MMarket Cap-0.02P/E (TTM)
2.7580High2.6200Low70.79KVolume2.7000Open2.7100Pre Close190.34KTurnover3.54%Turnover RatioLossP/E (Static)2.00MShares608.000052wk High0.22P/B5.49MFloat Cap2.105652wk Low--Dividend TTM2.00MShs Float125600.0000Historical High--Div YieldTTM5.09%Amplitude2.1050Historical Low2.6880Avg Price1Lot Size
About Sunshine Biopharma Company
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.
Company Profile
SymbolSBFM
Company NameSunshine Biopharma
Listing DateFeb 15, 2022
Founded2006
CEODr. Steve N. Slilaty, PhD
MarketNASDAQ
Employees44
Fiscal Year Ends12-31
Address333 Las Olas Way,CU4 Suite 433
CityFort Lauderdale
ProvinceFlorida
CountryUnited States of America
Zip Code33301
Phone1-945-515-0810
Company Executives
- Name
- Position
- Salary
- Dr. Steve N. Slilaty, PhD
- President and Chairman of the Board; Chief Executive Officer of the Company and Nora Pharma Inc
- 560.00K
- Malek Chamoun, C.P.A.
- Chief Development Officer
- --
- Camille Sebaaly
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 695.00K
- Marc Beaudoin
- Chief Operating Officer
- --
- Dr. Abderrazzak Merzouki, PhD
- Chief Science Officer and Director
- 260.00K
- Dr. Rabi Kiderchah, PhD
- Independent Director
- 80.00K
- Dr. Andrew Keller, PhD
- Independent Director
- 80.00K
- David Natan
- Independent Director
- 80.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.